NVOS Novo Integrated: Earnings per share for the last 12 months

Novo Integrated Sciences relies on a network of diagnostic centers and holistic clinics across North America. The company aims to expand its footprint by scaling primary care centers and implementing B2C telemedicine. However, a deficit in operating income and asset costs are creating a cash gap. The year-over-year EPS history (TTM) demonstrates current volatility, with the metric currently standing at 73.30.
Financial and market metric breakdowns for Novo Integrated Sciences (NVOS)

Investors are assessing the potential of Novo Integrated Sciences (NVOS) through earnings per share profitability trends. This metric measures the percentage change in annual net income, revealing the effectiveness of cost management and pricing power. Analyzing the annual EPS (TTM) change allows for the detection of demand reversals prior to the publication of financial reports. Logistics optimization via regional distributors minimizes operational risks, stabilizing this indicator. Growth in this figure confirms the business model's resilience to external shocks.